News & Articles

Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies

CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers

How a researcher at UC San Diego is elucidating the role of microglial dysfunction in brain trauma and disorders

The highly anticipated platform was launched by Repositive at AACR annual meeting

Earlham Institute boosts national capability in genomics and single cell analysis with ultra-high throughput sequencing platform from Illumina

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer

Read the story of a microvolume spectrophotometer demo instrument that impressed scientists so much it became the unanimous choice at the Royal Veterinary College, UK

New discoveries on devil facial tumor suggest that human cancer drugs may reduce the cancer mortality rate of Tasmanian devils - an endangered species naive to the Australian island of Tasmania